Home › Companies › Celldex Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Celldex Therapeutics, Inc.’s Form 8-K, filed June 26, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 25, 2026: 12 items on Celldex Therapeutics, Inc.’s Form 8-K, filed June 26, 2026: 9 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Celldex Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Celldex Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 26, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Harry H. Penner, Jr. (Chair of the Board) | 59,455,265 | 1,047,261 | 181,190 | -- | 4,402,319 | 98% | Elected | — |
| Elect Director: Anthony S. Marucci (Chief Executive Officer) | 60,218,830 | 282,968 | 181,918 | -- | 4,402,319 | 99.5% | Elected | — |
| Elect Director: Keith L. Brownlie | 59,858,683 | 644,110 | 180,923 | -- | 4,402,319 | 99% | Elected | — |
| Elect Director: Cheryl L. Cohen | 60,046,578 | 456,194 | 180,944 | -- | 4,402,319 | 99.2% | Elected | — |
| Elect Director: Herbert J. Conrad | 59,524,978 | 975,608 | 183,130 | -- | 4,402,319 | 98% | Elected | — |
| Elect Director: Rita I. Jain, M.D. | 59,495,870 | 1,000,240 | 187,606 | -- | 4,402,319 | 98% | Elected | — |
| Elect Director: James J. Marino | 59,910,902 | 591,402 | 181,412 | -- | 4,402,319 | 99.0% | Elected | — |
| Elect Director: Garry A. Neil, M.D. | 59,570,030 | 932,772 | 180,914 | -- | 4,402,319 | 98% | Elected | — |
| Elect Director: Denice Torres | 60,135,775 | 366,304 | 181,637 | -- | 4,402,319 | 99.3% | Elected | — |
| 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 64,712,039 | 174,706 | 199,290 | -- | -- | 99.7% | Approved | — |
| 3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares | 58,844,414 | 1,654,297 | 185,005 | -- | 4,402,319 | 97% | Approved | — |
| Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement. | 59,258,619 | 945,414 | 479,683 | -- | 4,402,319 | 98% | Approved | — |
Source: Celldex Therapeutics, Inc., Form 8-K, filed with the SEC on June 26, 2026 — read the filing on EDGAR.
Each item below shows how the 257 asset managers that disclosed a Celldex Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Anthony S. Marucci
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Anthony S. Marucci (Chief Executive Officer)”): 60,218,830 for, 282,968 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,353,810 for, 9,398 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,918 | 7,367 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,030 | 1,673 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Cheryl L. Cohen
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 60,046,578 for, 456,194 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,353,810 for, 9,399 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,918 | 7,368 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,030 | 1,673 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Denice Torres
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Denice Torres”): 60,135,775 for, 366,304 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,363,207 for, 1 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,679,284 | 1 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,317,703 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Garry A. Neil, M.D.
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Garry A. Neil, M.D.”): 59,570,030 for, 932,772 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,347,536 for, 15,672 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,916 | 7,369 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,030 | 1,673 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Harry H. Penner, Jr.
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Harry H. Penner, Jr. (Chair of the Board)”): 59,455,265 for, 1,047,261 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,343,846 for, 19,362 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,668,238 | 11,046 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,018 | 1,685 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Herbert J. Conrad
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Herbert J. Conrad”): 59,524,978 for, 975,608 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,347,497 for, 15,710 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,916 | 7,369 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,315,992 | 1,711 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: James J. Marino
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: James J. Marino”): 59,910,902 for, 591,402 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,353,809 for, 9,399 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,917 | 7,368 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,030 | 1,673 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Keith L. Brownlie
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Keith L. Brownlie”): 59,858,683 for, 644,110 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,350,132 for, 13,076 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,668,239 | 11,045 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,316,030 | 1,673 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Rita I. Jain, M.D.
Celldex Therapeutics, Inc.’s own tally for this item (“Elect Director: Rita I. Jain, M.D.”): 59,495,870 for, 1,000,240 against, per its Form 8-K filed June 26, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,356,933 for, 6,275 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,679,282 | 3 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,317,703 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR 2021 OMNIBUS EQUITY INCENTIVE PLAN, INCLUDING AN INCREASE IN THE NUMBER OF THE SHARES RESERVED FOR ISSUANCE THEREUNDER BY 3,400,000 SHARES TO 12,900,000 SHARES AND A CLARIFICATION REGARDING THE TAX WITHHOLDING PROVISIONS APPLICABLE TO AWARDS UNDER THE 2021 INCENTIVE PLAN.
Celldex Therapeutics, Inc.’s own tally for this item (“3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares”): 58,844,414 for, 1,654,297 against — passed, per its Form 8-K filed June 26, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,671,917 | 7,369 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,315,992 | 1,711 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 0 | 683,198 | 0 | 0 | Against |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 55,501 | 8,349 | 0 | 0 | Mixed |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 25,660,358 for, 700,985 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eversept Partners, LP | 1,556,298 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 3,217 | 0 | 0 | 0 | For |
| Keel Point, LLC | 1,865 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 1,561,380 for.
Combines 6 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
Celldex Therapeutics, Inc.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 59,258,619 for, 945,414 against — passed, per its Form 8-K filed June 26, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Celldex Therapeutics, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “SAY ON PAY” (2 managers, 25 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,679,282 | 3 | 2 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,317,703 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 26,357,463 for, 3,880 against, 2 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 8,548,588 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 5,732,474 | Withhold |
| Fidelity | 3,753,705 | 0 | 0 | 0 | For |
| State Street | 2,873,557 | 2,557 | 0 | 0 | For |
| T. Rowe Price | 2,851,156 | 0 | 0 | 0 | For |
| BlackRock | 2,834,713 | 0 | 0 | 0 | For |
| Commodore Capital LP | 2,105,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,925,741 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 1,556,298 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1,466,071 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 1,030,888 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,025,000 | 0 | 0 | 0 | For |
| Foresite Capital Management VI LLC | 879,713 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 831,196 | 0 | 0 | 0 | For |
| MONTANOVA CAPITAL, LLC | 801,097 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 754,119 | 0 | 0 | 0 | For |
| American Century | 748,497 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 716,270 | 0 | 0 | 0 | For |
| Charles Schwab | 630,658 | 0 | 0 | 0 | For |
| Vanguard | 598,989 | 0 | 0 | 0 | For |
| Nuveen | 565,045 | 0 | 0 | 0 | For |
| Woodline Partners LP | 561,629 | 0 | 0 | 0 | For |
| Northern Trust | 554,963 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 505,220 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 497,270 | 0 | 0 | 0 | For |
Institutional-manager reports, all 210 managers: 45,614,615 for, 369,971 against, 5,732,474 withheld, 455,951 abstained, 1,315 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026.
Celldex Therapeutics, Inc.’s own tally for this item (“2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 64,712,039 for, 174,706 against — passed, per its Form 8-K filed June 26, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 26,363,169 for, 39 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,679,285 | 0 | 0 | 0 | For |
| Fidelity | 4,430,076 | 0 | 0 | 0 | For |
| BlackRock | 2,612,329 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,923,039 | 0 | 0 | 0 | For |
| State Street | 1,317,664 | 39 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,049,614 | 0 | 0 | 0 | For |
| American Century | 683,198 | 0 | 0 | 0 | For |
| Charles Schwab | 630,314 | 0 | 0 | 0 | For |
| TIAA | 554,035 | 0 | 0 | 0 | For |
| Hartford | 522,084 | 0 | 0 | 0 | For |
| Dimensional | 296,337 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,708 | 0 | 0 | 0 | For |
| Federated Hermes | 258,827 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 197,835 | 0 | 0 | 0 | For |
| Equitable | 159,151 | 0 | 0 | 0 | For |
| Northwestern Mutual | 152,685 | 0 | 0 | 0 | For |
| First Trust | 127,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,132 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,474 | 0 | 0 | 0 | For |
| DWS | 96,496 | 0 | 0 | 0 | For |
| John Hancock | 91,334 | 0 | 0 | 0 | For |
| JPMorgan | 83,467 | 0 | 0 | 0 | For |
| Brighthouse | 76,162 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 63,850 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 61,385 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 78,492,072 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.33% |
| 2 | Fidelity | 5.64% |
| 3 | BlackRock | 3.33% |
| 4 | T. Rowe Price | 2.45% |
| 5 | State Street | 1.68% |
| 6 | MUTUAL FUND SERIES TRUST | 1.34% |
| 7 | American Century | 0.87% |
| 8 | Charles Schwab | 0.80% |
| 9 | TIAA | 0.71% |
| 10 | Hartford | 0.67% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Wellington | 10.89% |
| 2 | Kynam Capital Management, LP | 7.30% |
| 3 | Fidelity | 4.78% |
| 4 | State Street | 3.66% |
| 5 | T. Rowe Price | 3.63% |
| 6 | BlackRock | 3.61% |
| 7 | Commodore Capital LP | 2.68% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.45% |
| 9 | Eversept Partners, LP | 1.98% |
| 10 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.87% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 10.91% | 13F |
| Kynam Capital Management, LP | 8.28% | DEF14A |
| BlackRock | 6.84% | 13F |
| FMR LLC | 6.19% | DEF14A |
| Vanguard Group | 5.13% | 13F |
| FMR (Fidelity) | 4.78% | 13F |
| Point72 | 4.11% | 13F |
| State Street | 3.57% | 13F |
| T. Rowe Price | 2.66% | 13F |
| Millennium Management | 1.60% | 13F |
Percentages above are of 78,492,072 shares outstanding, as reported by Celldex Therapeutics, Inc. on its Form 10-Q dated April 29, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Celldex Therapeutics, Inc.’s 10-Q dated April 29, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Celldex Therapeutics, Inc.'s shareholder meeting held June 25, 2026, in the 2025-2026 proxy season, 257 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 3,086 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — Celldex Therapeutics, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Celldex Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 26, 2026.
Celldex Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.